Annual Total Liabilities
$130.43 M
+$70.67 M+118.27%
31 December 2023
Summary:
Armata Pharmaceuticals annual total liabilities is currently $130.43 million, with the most recent change of +$70.67 million (+118.27%) on 31 December 2023. During the last 3 years, it has risen by +$109.77 million (+531.34%). ARMP annual total liabilities is now at all-time high.ARMP Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$149.21 M
-$5.20 M-3.37%
30 September 2024
Summary:
Armata Pharmaceuticals quarterly total liabilities is currently $149.21 million, with the most recent change of -$5.20 million (-3.37%) on 30 September 2024. Over the past year, it has increased by +$24.06 million (+19.23%). ARMP quarterly total liabilities is now -15.64% below its all-time high of $176.87 million, reached on 31 March 2024.ARMP Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARMP Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +118.3% | +19.2% |
| 3 y3 years | +531.3% | +688.8% |
| 5 y5 years | +3721.5% | +1235.6% |
ARMP Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +531.3% | -15.6% | +688.8% |
| 5 y | 5 years | at high | +3721.5% | -15.6% | +1305.0% |
| alltime | all time | at high | +6764.6% | -15.6% | +8203.3% |
Armata Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $149.21 M(-3.4%) |
| June 2024 | - | $154.41 M(-12.7%) |
| Mar 2024 | - | $176.87 M(+35.6%) |
| Dec 2023 | $130.43 M(+118.3%) | $130.43 M(+4.2%) |
| Sept 2023 | - | $125.15 M(+52.5%) |
| June 2023 | - | $82.07 M(-4.9%) |
| Mar 2023 | - | $86.33 M(+44.5%) |
| Dec 2022 | $59.75 M(+34.7%) | $59.75 M(+26.3%) |
| Sept 2022 | - | $47.30 M(-0.8%) |
| June 2022 | - | $47.69 M(+3.2%) |
| Mar 2022 | - | $46.23 M(+4.2%) |
| Dec 2021 | $44.37 M(+114.8%) | $44.37 M(+134.6%) |
| Sept 2021 | - | $18.92 M(-3.8%) |
| June 2021 | - | $19.66 M(+4.4%) |
| Mar 2021 | - | $18.83 M(-8.8%) |
| Dec 2020 | $20.66 M(+90.3%) | $20.66 M(-1.9%) |
| Sept 2020 | - | $21.06 M(+6.2%) |
| June 2020 | - | $19.82 M(+86.7%) |
| Mar 2020 | - | $10.62 M(-2.2%) |
| Dec 2019 | $10.86 M(+218.1%) | $10.86 M(-2.8%) |
| Sept 2019 | - | $11.17 M(-9.1%) |
| June 2019 | - | $12.29 M(+163.9%) |
| Mar 2019 | - | $4.66 M(+36.4%) |
| Dec 2018 | $3.41 M(+0.2%) | $3.41 M(-9.4%) |
| Sept 2018 | - | $3.77 M(+11.4%) |
| June 2018 | - | $3.38 M(+8.7%) |
| Mar 2018 | - | $3.11 M(-8.7%) |
| Dec 2017 | $3.41 M(-59.6%) | $3.41 M(-15.3%) |
| Sept 2017 | - | $4.02 M(-23.3%) |
| June 2017 | - | $5.25 M(-31.5%) |
| Mar 2017 | - | $7.65 M(-9.2%) |
| Dec 2016 | $8.43 M(-55.1%) | $8.43 M(+8.0%) |
| Sept 2016 | - | $7.81 M(+0.2%) |
| June 2016 | - | $7.79 M(-59.7%) |
| Mar 2016 | - | $19.36 M(+3.1%) |
| Dec 2015 | $18.78 M(-25.4%) | $18.78 M(+2.0%) |
| Sept 2015 | - | $18.41 M(-20.9%) |
| June 2015 | - | $23.28 M(-44.1%) |
| Mar 2015 | - | $41.68 M(+65.5%) |
| Dec 2014 | $25.18 M(-60.6%) | $25.18 M(+47.4%) |
| Sept 2014 | - | $17.08 M(-57.6%) |
| June 2014 | - | $40.28 M(-31.1%) |
| Mar 2014 | - | $58.46 M(-8.4%) |
| Dec 2013 | $63.84 M(+599.4%) | $63.84 M(+3452.5%) |
| Dec 2012 | $9.13 M(-16.4%) | - |
| Sept 2009 | - | $1.80 M(-14.4%) |
| June 2009 | - | $2.10 M(-80.7%) |
| Mar 2009 | - | $10.88 M(-0.4%) |
| Dec 2008 | $10.92 M(-10.7%) | $10.92 M(-10.8%) |
| Sept 2008 | - | $12.24 M(-7.6%) |
| June 2008 | - | $13.25 M(+18.0%) |
| Mar 2008 | - | $11.23 M(-8.2%) |
| Dec 2007 | $12.23 M | $12.23 M(+15.0%) |
| Sept 2007 | - | $10.64 M(-22.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2007 | - | $13.70 M(+16.3%) |
| Mar 2007 | - | $11.78 M(-2.7%) |
| Dec 2006 | $12.10 M(-33.6%) | $12.10 M(-34.5%) |
| Sept 2006 | - | $18.46 M(-0.8%) |
| June 2006 | - | $18.60 M(-3.0%) |
| Mar 2006 | - | $19.18 M(+5.2%) |
| Dec 2005 | $18.23 M(-9.8%) | $18.23 M(-0.1%) |
| Sept 2005 | - | $18.25 M(-11.3%) |
| June 2005 | - | $20.57 M(+1.3%) |
| Mar 2005 | - | $20.31 M(+0.5%) |
| Dec 2004 | $20.20 M(-13.8%) | $20.20 M(-5.5%) |
| Sept 2004 | - | $21.38 M(-12.9%) |
| June 2004 | - | $24.56 M(+2.6%) |
| Mar 2004 | - | $23.93 M(+2.1%) |
| Dec 2003 | $23.44 M(-49.1%) | $23.44 M(+4.2%) |
| Sept 2003 | - | $22.50 M(-36.2%) |
| June 2003 | - | $35.23 M(-21.4%) |
| Mar 2003 | - | $44.81 M(-2.7%) |
| Dec 2002 | $46.07 M(+0.9%) | $46.07 M(-3.6%) |
| Sept 2002 | - | $47.77 M(-4.5%) |
| June 2002 | - | $50.02 M(+61.0%) |
| Mar 2002 | - | $31.07 M(-32.0%) |
| Dec 2001 | $45.65 M(+86.0%) | $45.65 M(+62.4%) |
| Sept 2001 | - | $28.11 M(+34.3%) |
| June 2001 | - | $20.93 M(-12.2%) |
| Mar 2001 | - | $23.82 M(-2.9%) |
| Dec 2000 | $24.54 M(+266.3%) | $24.54 M(+97.6%) |
| Sept 2000 | - | $12.42 M(+84.1%) |
| June 2000 | - | $6.75 M(+7.1%) |
| Mar 2000 | - | $6.30 M(-6.0%) |
| Dec 1999 | $6.70 M(+59.5%) | $6.70 M(+55.8%) |
| Sept 1999 | - | $4.30 M(-2.3%) |
| June 1999 | - | $4.40 M(+12.8%) |
| Mar 1999 | - | $3.90 M(-7.1%) |
| Dec 1998 | $4.20 M(0.0%) | $4.20 M(+2.4%) |
| Sept 1998 | - | $4.10 M(-6.8%) |
| June 1998 | - | $4.40 M(-10.2%) |
| Mar 1998 | - | $4.90 M(+16.7%) |
| Dec 1997 | $4.20 M(-25.0%) | $4.20 M(-6.7%) |
| Sept 1997 | - | $4.50 M(-6.3%) |
| June 1997 | - | $4.80 M(-2.0%) |
| Mar 1997 | - | $4.90 M(-12.5%) |
| Dec 1996 | $5.60 M(+33.3%) | $5.60 M(+9.8%) |
| Sept 1996 | - | $5.10 M(-17.7%) |
| June 1996 | - | $6.20 M(+44.2%) |
| Mar 1996 | - | $4.30 M(+2.4%) |
| Dec 1995 | $4.20 M(+10.5%) | $4.20 M(+27.3%) |
| Sept 1995 | - | $3.30 M(-5.7%) |
| June 1995 | - | $3.50 M(-5.4%) |
| Mar 1995 | - | $3.70 M(-2.6%) |
| Dec 1994 | $3.80 M(+100.0%) | $3.80 M(+22.6%) |
| Sept 1994 | - | $3.10 M(-3.1%) |
| June 1994 | - | $3.20 M(+68.4%) |
| Dec 1993 | $1.90 M | $1.90 M |
FAQ
- What is Armata Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals annual total liabilities year-on-year change?
- What is Armata Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Armata Pharmaceuticals?
- What is Armata Pharmaceuticals quarterly total liabilities year-on-year change?
What is Armata Pharmaceuticals annual total liabilities?
The current annual total liabilities of ARMP is $130.43 M
What is the all time high annual total liabilities for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high annual total liabilities is $130.43 M
What is Armata Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, ARMP annual total liabilities has changed by +$70.67 M (+118.27%)
What is Armata Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ARMP is $149.21 M
What is the all time high quarterly total liabilities for Armata Pharmaceuticals?
Armata Pharmaceuticals all-time high quarterly total liabilities is $176.87 M
What is Armata Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, ARMP quarterly total liabilities has changed by +$24.06 M (+19.23%)